Du Xue-lian, Sheng Xiu-gui, Zhong Yan, Li Da-peng, Liu Nai-fu
Department of Gynecologic Oncology, Shandong Cancer Hospital, Jinan, China.
Zhonghua Fu Chan Ke Za Zhi. 2013 May;48(5):348-51.
To evaluate the clinical value of sentinel lymph nodes (SLN) in predicting pelvic lymph node status for early cervical squamous cell carcinoma, and approach the clinical significance of SLN detection for guiding radical abdominal trachelectomy (RAT).Outcomes of follow up and fertility were also observed.
A total of 31 patients with stageIa2-Ib1 squamous cell carcinoma planned to be given RAT and pelvic lymphadenectomy were enrolled. (99m)Tc-labeled phytate was injected before surgery.Intraoperatively, SLN were identified, excised, and submitted to fast frozen section.Systematic bilateral pelvic lymphadenectomy was performed, and then RAT was performed in patients with negative SLN. All nodes were sent for routine pathological examination and immunostained with anti-cytokeratin antibody to detect micrometastases.
SLN were detected in all patients (100%,31/31). A total of 109 SLN were identified with a mean number of 3.5 per patient.Of these, SLN of 2 patients were positive on frozen sections and proved to be metastasis by final pathologic examination and quitted the RAT. No missed micrometastasis was found using immunohistochemical staining in SLN and other lymph nodes using histologically node-negative cases. No false negative cases was found and the negative value was 100% (31/31). The sensitivity, accuracy, and false negative rates were 100%, 100%, and 0, respectively. Perioperative complications occurred in 5 patients including 2 cases of bladder injury and 3 cases of uterine artery injury.No relapses occurred during follow-up.Five of 19 patients with procreative desire conceived pregnancies (4 spontaneous abortion and 1 premature birth) after surgery.
The identification of SLN using (99m)Tc-labeled phytate could predict the pelvic lymph node status in early stage cervical cancer. Under the guidance of SLN detection, RAT is a feasible operative modality with well prognosis and low complications for young patients who desire to preserve reproductive function.
评估前哨淋巴结(SLN)在预测早期宫颈鳞状细胞癌盆腔淋巴结状态中的临床价值,并探讨SLN检测对指导腹式根治性宫颈切除术(RAT)的临床意义。同时观察随访结果及生育情况。
共纳入31例计划行RAT及盆腔淋巴结清扫术的Ia2-Ib1期鳞状细胞癌患者。术前注射(99m)Tc标记的植酸盐。术中识别、切除SLN,并送快速冰冻切片检查。进行双侧系统性盆腔淋巴结清扫术,SLN阴性的患者随后行RAT。所有淋巴结均送常规病理检查,并采用抗细胞角蛋白抗体进行免疫染色以检测微转移。
所有患者均检测到SLN(100%,31/31)。共识别出109枚SLN,平均每位患者3.5枚。其中,2例患者的SLN冰冻切片呈阳性,最终病理检查证实有转移,放弃行RAT。在组织学检查淋巴结阴性的病例中,SLN及其他淋巴结采用免疫组化染色未发现漏诊的微转移。未发现假阴性病例,阴性预测值为100%(31/31)。灵敏度、准确率和假阴性率分别为100%、100%和0。5例患者发生围手术期并发症,包括2例膀胱损伤和3例子宫动脉损伤。随访期间无复发。19例有生育意愿的患者中,5例术后怀孕(4例自然流产,1例早产)。
使用(99m)Tc标记的植酸盐识别SLN可预测早期宫颈癌的盆腔淋巴结状态。在SLN检测的指导下,RAT对于希望保留生殖功能的年轻患者是一种可行的手术方式,预后良好且并发症少。